Transperineal prostate biopsy improves cancer detection, especially in repeat biopsies, with fewer complications.

A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.

Tests to check for bladder cancer include physical exams, urine tests, and imaging. Biopsy or cystoscopy may help confirm a diagnosis. If you’re at high risk, at-home tests might help you screen ...

Cretostimogene monotherapy achieves a 75.5% complete response rate in high-risk, BCG-unresponsive non-muscle invasive bladder cancer patients. The treatment maintains a 46% complete response at 12 ...

A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who had blue light vs white light cystoscopy. Patients who received blue light ...

Formula One team owner Eddie Jordan has died, aged 76, after a year-long battle with prostate and bladder cancer. The Irishman revealed in December he was suffering from bladder and prostate ...

Way back in March and April, I was diagnosed with bladder and prostate cancer, and then it spread into the spine and the pelvis, so it was quite aggressive.' In an urgent warning to listeners ...

1–3 Standard management approaches include outpatient flexible cystoscopy, followed by transurethral resection of bladder tumour (TURBT), 4 which ... to correct treatment using an outpatient biopsy ...

A womb biopsy is when a sample of tissue is taken from the lining of the womb. This is also called an endometrial biopsy. Your doctor sends the sample to the laboratory. This is where a pathologist ...

A biopsy means removing a sample of cells or tissue and looking at it under a microscope. You may have a liver biopsy to help diagnose liver cancer. But not everyone needs to have one. Doctors can ...

prior results from multiple randomized controlled clinical trials. · Risk of recurrence at 3-years was significantly reduced following BLC vs. WLC (HR, 0.62; 95% CI, 0.45-0.86; p0.01). The 38% ...

OSLO, Norway, March 14, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal ...